thanks completion first of innovation with growth for new announcement stream and arrangements, call. Good M&A evening, on fronts, technology guidance. updates above-expectations various an first a and our new our agenda. go-lives, the strong including Tonight, customer the and quarter integration had quarter adjusted Evolent the EBITDA joining client line revenue with of in work we'll cover
our focus revenue on growth account our This $XX enabling year-over-year. Performance in XX% in top normalizing XX% $XXX.X XX% our by million highlights Revenue grew This after guide and technology XX% million, NIA XX.X% arrangements membership by revenue of and from of specialty is to million. and specialty first for Year-over-year, our QX years few our $XXX just revenue, ago, X of January now strong first strategy. totaled Let of the revenue agreements.
Evolent offerings the me result from care care end total Suite exceeded organization high driven results. provide services approximately for growth a reported XXXX. almost new specialty quarter up as specialty acquisition
On unique the we and just quarter. new Medicaid averaged or XX.X million products front, the net first XX.X Total average. of quarter in membership per during members, members million implementations eclipsed over redeterminations member product on unique X the
in at with On the our EBITDA was of midpoint profitability front, the million. line adjusted guidance $XX.X
$XXX.X cash after in Our a as what associated historically progresses. that equivalents moderate year working with always capital remained million cash cash with requirements and the strong is high position outflow quarter higher
shareholder three, Let allocation. me organic each now capital creation of: X expanding strong principles disciplined value on two, of our update profitability; you and for growth; One,
On announced the first we of building our the today announcing during we're agreements X that new -- partnership. first quarter. organic agreements successful Molina, of are principle signed revenue with long-term that highly on revenue we growth, new Two
these Molina live. live. least Mississippi X increases Carolina The Carolina of at and quarter cardiology annual and the South together contribution X will performance implementing year. revenue of We lives Medicaid to $XX by South Financially, states with presence million contribute the our Mississippi. anticipate both exchange go and We across oncology new of fourth to and both in states states anticipate once this be these we solutions these impact suite implementing addition of after
significant partnership scope our to within expanding the be Suite, we the today, revenue partner. will for to excluding leaving opportunity and solutions of current total continue believe what be Molina below opportunity Our new our at Performance XX% like a services provide of MSK impact we
plan in This health costs, signed offering We we contribute will the of we a orthopedic revenue MSK implementing will the year-to-date. EBITDA provided several million adjusted agreement surgery adjusted year-end X Evolent earnings $X exit new Coast. help us our in bridge and target.
Today's to go-get anticipate health announcements the thousand for This revenue third Specialty EBITDA with contract specialty the quarterly hundred towards East Medicaid Technology in across and illustration solution contract third Services members. utilization to quarter a outcomes. manage our is XXXX be bring Medicaid agreements Our plan long-standing adding achieving new this
for Services and revenue Performance and major specialty across for Molina In cardiology in go-lives. new we Florida productive Blue. and oncology included including to QX in for go-lives Suite, the Performance In multiple new Suite total, go-lives Florida launched addition for Suite. plan the successful These XX for and agreements, health Technology was customers geographies cardiology
the perspective, back macro synergies During members. acquisition.
From from began Centene NIA remains also very a we Services revenue the national a promised for strong. we million February, this our a agreement in with industry Technology and several announced the Suite significant portion MSK quarter, of initial implementation demand Recall, covering fulfilling
our proposition, inbound pressure opportunities. our product utilization health Beyond care sales health are margin plan normal accelerating core pressure value and
that savings the for making current plans. more growing of specialty environment, and is outside typical in high-cost belief health levers management a focus limited Our are specialty critical care
large remains and As both in our by health strong, a regional these driven very result pipeline of national factors, plans. sales interest
of shortly. $XXX of these by result XXXX the raising dynamics, John guidance as are midpoint million, revenue for will of all our As we a detail
achievement was our project The customers announce the limited wound March, Moving agreement of and NIA achieve our down and transition worked we since services of hundreds involving important continue serving excited transition. to the this to want company's in the former to January second to Evolent all professionals transition quarter our another the our year-end of This expanding of EBITDA that thank in with Most had we able important importantly, the tirelessly in IT were history, disruption.
I with step who I'm rate largest to of marks complex profitability, we successfully through place XXXX globally. million priority in NIA $XX synergies. owner. weekends teams the transition most operating NIA's run cost target towards
we intelligence specialty share our continue there to in providing and on investing superior initial Evolent opportunity significant that to I'm Next, case user enhancing testing. work is reduce experience. product that the cost Based believe while review artificial for a the quality we service our at or opportunity through far, thus pleased maintaining even a
streams redeploy human and our As able additional expect benefit our improve higher-value our product we value that be proposition. of our pool we'd AI investments, capital work to to
making We expect begin a these more benefits impact XXXX. to in significant
our growth demonstrate of continue balanced our Third, our and benefit adjusted our the care from value-based products, to products and non-risk account risk our annual for of both approach approximately in to specialty nonrisk QX with results earnings EBITDA. XX%
utilization run Performance the in do confident have and XXXX in contractual prevalence utilization increases the in we our us As early in annual and detail, EBITDA across guidance. QX John point year.
Those of protections QX, we our around the have will changes will impact will guide. visibility $XXX to increase than data this the exit data million and Suite saw in business we because But visibility our factors QX for risk because commitment rate of and share detail, in adjusted remain available is moderated that population because lower our John increased other year, our typical across
substantial our continuing drive a expense these SG&A talent I feel growth. despite able team maintaining been for efficiency to drive orientation. while Finally, with I'm we versus grow proud efficiencies culture to and as QX down sequentially And revenue we've the strong of
our to over our disciplined communications help Regarding strong our principles the talked building remain their leverage members leadership last position innovation, our conditions consistent and accelerate pursuing services of our third carefully with and allocation, to their of value-based specialty which managing accretive respect care. ensuring organic are to their innovation, targets capital investment families to few have in years, in more theme moments M&A organic we consistently need. about With navigate
Our decision-making Suite. that quality, with which our solution, into an thus member shared Performance far engaged we the helps primarily most through We've our this end-of-life drive highest strong care. is opportunity bundle addressed efficient belief
care integrated monitor oncology the care accelerating the with cardiology total monitor by our our we're Our data member U.K.-based to the across the platform solutions, aligning care and patient with that palliative status Today, of improve with announced we large strategic Service work announcing Careology, goals their what shared of solution partnership navigation robust to to Cross cost engagement signs generating Blue chemotherapy, of for be shows materially overall have versus into Blue being reducing when identified end-of-life Health quo digital of privately plan higher caregivers also referrals platform patients held rates greater overall The the navigation values with most with offer and this decision-making report extensively cancer cancer. with better to order Careology and August, believe we while to life.
Last company in most to and Shield initial care to we patients is care quality system with clinical partner U.K. a a a diagnosed National importantly, pilot health symptoms associated program connect is available. used well-being. vital and a
and as potentially a solution the for and In will the innovating From the integrate right the has market. doing Evolent the a Suite We addition, services and good in manage payer our Evolent believe in members, patient cost both long-term help arrangement in a way. believe the perspective, and platform offering States our manages and capital-efficient product in bundled navigation business secured appointments quality solution an overall care process.
We schedules is the and United of example technology of become this Performance distribute this so future. another the exclusive to offering
to it to is I step on financials want back I our in a future. Before the where Evolent guidance, comment believe and and through hand talk headed John take I to
believe growth are we differentiated the XX% execute growing currently over built and incredible The an believe ability we profitability, term. at customer we are driving our in what of profitability proud cash flow. specialty annually, to and long over and organically and a is indicators have innovate confidence strong to platform, First, strong
innovative for rising artificial and need in the manage health and important believe, is areas publicly come.
And navigation, expansion, requiring utilization patient and to pressures significant environment an late accelerate pressures and small care as challenged for environment creates across our third, utilization We aggressively financial given mid-cap opportunities create, Second, platform. traded years to our been the care. to health I operational specialty exception. understand This organizations plans, investing a provide on no more for intelligence company will solutions innovation specialty meaningful of like our has Evolent all opportunity
future tools remain about hand available committed fully to we using it let optimistic shareholder that, our value ensure to and me very creation.
With all John. However, the to
